Objective-Whether tobacco smoking causally affects white and red blood cells and thrombocyte counts is unknown. Using a Mendelian randomization approach, we tested the hypothesis that smoking causes increases in these blood cell indices. Approach and Results-We included 104 607 white Danes aged 20 to 100 years from the Copenhagen General Population Study with information on blood cell indices, smoking habits, and CHRNA3 (alpha 3 nicotinic cholinergic receptor) rs1051730 genotype, where the T allele causes higher tobacco consumption; 41 759 were former smokers and 17 852 current smokers. In multivariable adjusted observational analyses and compared with never smokers, white blood cells were associated with up to 19% increases, thrombocytes with up to 4.7% increases, and red blood cell indices with up to 2.3% increases in former and current smokers. All associations were dose dependent, with tobacco consumption but for white blood cells and thrombocytes also dependent on smoking cessation time in former smokers; highest increases were for <1-year smoking cessation and lowest increases for >10-year smoking cessation. In age-and sex-adjusted genetic analyses, percent differences per T allele increase in current smokers were 1.15% (95% CI, 0.61%-1.68%) for leukocytes, 1.07% (0.38%-1.76%) for neutrophils, 1.34% (0.66%-2.02%) for lymphocytes, 1.50% (0.83%-2.18%) for monocytes, −0.60% (−1.91% to 0.74%) for eosinophils, 0.17% (−0.94% to 1.29%) for basophils, 0.38% (−0.17% to 0.93%) for thrombocytes, 0.04% (−0.14% to 0.23%) for erythrocytes, 0.34% (0.17% to 0.50%) for hematocrit, 0.26% (0.09% to 0.43%) for hemoglobin, and 0.29% (0.18% to 0.41%) for mean corpuscular volume. Conclusions-Smoking causes increased blood leukocytes, neutrophils, lymphocytes, and monocytes, as well as increased hematocrit, hemoglobin, and mean corpuscular volume. The observational smoking relationships were long term for white blood cells and short term for red blood cell indices. Visual Overview-An online visual overview is available for this article. 
W orldwide, tobacco smoking is responsible for millions of premature deaths each year. 1 The detrimental effects of smoking seem not only to be local but also systemic. Indeed, smoking is associated with an increased risk of chronic obstructive pulmonary disease (COPD) and lung cancer but also with extrapulmonary diseases such as cardiovascular disease, diabetes mellitus, and bladder cancer. [2] [3] [4] [5] [6] In this context, observational studies have associated smoking with end products of hematopoiesis [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] and hematologic neoplasms. [19] [20] [21] [22] Although all studies have observed a positive association between smoking and total white blood cell counts, there have been some conflicting results for the subpopulations. 9, 10, 13 Conflicting results have also been observed in the association between smoking and thrombocytes and some red blood cell indices. 8, 10, 13, 16, 17 Since observational studies are usually prone to confounding and reverse causation, it is still uncertain whether tobacco smoking causally influences the hematopoietic system. This is an important question, as smoking is a potential reversible risk factor, and if smoking is causally associated with the hematopoietic system, it can ultimately change the understanding of many hematologic diseases. 23 Usually, the gold standard in establishing causal relationships is randomized, double-blinded, placebo-controlled clinical trials; however, some exposures such as tobacco smoking would be unethical or impractical to study in humans using such a study design. Although research on model organisms could experimentally address such study questions, for example, different biological effects of tobacco smoking from firsthand to thirdhand smoking, 24, 25 this often cannot be extrapolated to human organisms. An alternative approach is to use genetic variants as proxies of modifiable exposures in a Mendelian randomization analysis. 26, 27 Using a genetic variation well-known to cause higher tobacco consumption, [28] [29] [30] [31] [32] it is possible to assess the causal relationship between tobacco smoking and blood cells ( Figure I in the online-only Data Supplement). Since the distribution of alleles is random at conception, genetic variants are generally not associated with potential confounders and, as genes are present at birth, genetic variants are not susceptible to reverse causation.
In European populations, the polymorphism rs1051730 in proximity to the CHRNA3 (alpha 3 nicotinic cholinergic receptor) gene is in full linkage disequilibrium with the polymorphism rs16969968 in the CHRNA5 (alpha 5 nicotinic cholinergic receptor) gene. 33, 34 The latter results in change from an aspartic acid [D] to asparagine [N] at position 398 of the human alpha 5 nicotinic acetylcholine receptor subunit. 34 Human and animal studies show that the consequent structural change in the alpha 5 subunit increases nicotine intake and results in higher amount of tobacco consumption in current smokers and in higher nicotine metabolite (cotinine) levels. [34] [35] [36] [37] The CHRNA3 rs1051730 does not result in an amino acid change and thus is unlikely to be of functional importance. However, the T allele of CHRNA3 rs1051730 has previously been associated with higher tobacco consumption, [28] [29] [30] [31] [32] and although not the causal gene variant for the association, it can be used as a genetic instrument for smoking heaviness due to the high linkage with CHRNA5 rs16969968.
By using a Mendelian randomization approach in the Copenhagen General Population Study with 104 607 individuals of whom 59 611 were tobacco smokers, we tested the hypothesis that smoking causes increased white blood cells, thrombocytes, and red blood cell indices.
Materials and Methods
Data that further support the findings of this study are available from the corresponding author upon reasonable request.
Study Population
We included 104 607 individuals from the Copenhagen General Population Study, an ongoing population-based cohort study, recruited from November 2003 through March 2015 (response rate 43%). 38, 39 In Denmark, all individuals are assigned a unique identification number at birth or immigration and registered in the National Danish Civil Registration System since 1968. Thus, individuals aged 20 to 100 years were randomly selected from the Danish Civil Registration System to reflect the adult white population of Danish descent. 40 Individuals completed a comprehensive questionnaire, underwent a physical examination, and gave blood for biochemical and genetic analyses. Questionnaires were reviewed in detail at the day of attendance by a healthcare professional together with the participant.
The study was approved by Herlev and Gentofte Hospital and a Danish ethical committee and conducted according to the Declaration of Helsinki (approval number: H-KF-01-144/01). Written informed consent was obtained from all participants.
Tobacco Smoking
Smoking status was self-reported and defined as never, former, or current smoker. Tobacco consumption was investigated in the form of prolonged cumulative exposure and immediate daily exposure based on information on age at smoking initiation and cessation, duration of tobacco consumption, and amount of consumed tobacco (number of daily consumed cigarettes, cheroots, and cigars and grams of weekly consumed pipe tobacco). A single cigarette equaled 1 g of tobacco, a single cheroot equaled 0.8 g of tobacco, and a single cigar equaled 5 g of tobacco. Cumulative tobacco consumption was calculated in packyears, that is, 1 pack-year was 20 cigarettes or equivalent smoked daily for 1 year, whereas daily tobacco consumption was calculated in grams per day.
Blood Cells
Individuals were randomly nonfasting when blood samples were drawn from the venous circulation on the day of attendance and measured on fresh samples using the ADVIA 120 Hematology System (Siemens Healthineers, Erlingen, Germany). Blood samples were analyzed in a time span of ≈2000 days, where analyses were subjected to daily precision testing using an internal quality control material and monthly accuracy testing using an external quality control program. Leukocytes, including differential counts, thrombocytes, and erythrocytes were reported in total numbers (10 9 or 10 12 cells/L). Hematocrit, hemoglobin, mean corpuscular volume, and mean corpuscular hemoglobin concentration were reported as a proportion of 1.0, g/dL, fL, and mmol/L, respectively.
Genotyping
Genotyping was conducted blind to information on tobacco smoking and blood cell values. DNA from all individuals were isolated from whole blood and stored at −45°C. The ABI PRISM 7900HT Sequence Detection System (Applied Biosystems Inc) was used to genotype CHRNA3 rs1051730 with TaqMan assays. Genotyping was verified by DNA sequencing. As we performed reruns twice, call rates were >99.8%. Primers and probe sequences are available from the authors upon request.
Potential Confounders
Information on potential confounders was acquired from the questionnaire, physical examination, and 2 national registries. Potential confounders were chosen because they have been associated with blood cell indices and smoking. 38, 39 Body mass index (BMI) was calculated as measured weight divided by measured height squared (kg/ m 2 ). Alcohol consumption was reported in units per week (1 unit=12 g of alcohol). Leisure-time physical activity was reported according to hours per week and degree of activity. Education was based on years attending school. Income was reported as annual household income. Infectious disease within the past 4 weeks was if the individual reported fever, bronchitis, or urinary tract infections up to 4 weeks before the day of enrollment. Chronic diseases included COPD, cancer, ischemic heart disease, and diabetes mellitus. 
Statistical Analyses
STATA/SE 13.1 (StataCorp LP, StataCorp, College Station, TX) was used. Deviation from Hardy-Weinberg equilibrium for the CHRNA3 rs1051730 genotype was investigated using the χ 2 test; deviation may suggest genotyping or population sampling errors. 26 Since blood cell indices were not normally distributed (Figures II and III in the onlineonly Data Supplement), values were logarithmically transformed. The association between tobacco smoking, CHRNA3 rs1051730, and blood cell indices were investigated using multiple linear regression models, which allowed for adjustment of potential confounders.
In observational analyses, associations were investigated according to smoking status and cumulative and daily tobacco consumption. Former smokers were divided according to time since smoking cessation to investigate long-term versus short-term association of tobacco smoking with blood cell values. Observational analyses were adjusted for potential confounders that could be associated with tobacco smoking or blood cell values, that is, for age, sex, BMI, alcohol consumption, leisure-time physical activity, education, income, infectious disease within the past 4 weeks, and prevalent chronic diseases. Information on potential confounders were 99.2% complete; information on BMI, alcohol consumption, leisure-time physical activity, education, income, and infectious disease within the past 4 weeks was lacking in few individuals, and we therefore performed multiple imputation using chained equations to fill out the missing values. 43 In total, 50 imputations were made on each missing variable for each individual using predictive mean matching for continuous variables, logistic regression for binary variables, and multinomial logistic regression for nominal variables by choosing age and sex as main predictors, which we had complete information on, and one as the random number seed. All 50 imputations for each missing variable for each individual were used in the multiple linear regression models in the observational analyses. Nonetheless, results from complete case analyses are also provided in the online-only Data Supplement.
In the genetic analyses, association with cumulative and daily tobacco consumption was confirmed using multiple linear regression models. 26 Association between the CHRNA3 rs1051730 genotype and potential confounders was investigated using linear and logistic regression models as appropriate. Genetic analyses were adjusted for age and sex only, as genotypes generally are not associated with confounders. We also investigated the association between genetically determined tobacco consumption (denoted cigarettes/day) and blood cell indices by using CHRNA3 rs1051730 in an instrumental variable analysis using the control function estimator in 2 stages. 26, 44 For the control function estimator, we used the predicted values and residuals from the first-stage linear regression as variables in the secondstage linear regression to investigate the association with blood cell indices adjusted for age and sex. We evaluated the strength of the instrumental variable by examining the F statistic from the first-stage regression: F>10 indicates sufficient strength to ensure statistical reliability of the instrumental variable estimates. Data are summarized as medians with the 25th and 75th percentiles or numbers (%). *12 g=1 unit of alcohol. †Being completely sedentary or doing light physical activity <2 h/wk. ‡<9 y of school attendance. §Annual household income <200 000 DKK (Danish Kroner). ‖Fever, bronchitis, or urinary tract infection within the past 4 wk before enrollment in the study. ¶Tobacco-related cancers included cancers affecting the oral cavity, nasal cavity and paranasal sinuses, pharynx, larynx, esophagus, lung, kidney, bladder and urinary tract, liver and biliary tract, stomach, pancreas, colon/rectum/anus, cervix, and myeloid leukemia. Non-tobacco-related cancers included cancers affecting the other organs except for nonmelanoma skin cancer (including squamous and basal cell carcinomas).
For genetic sensitivity analyses, we used other models with different adjustment/exclusion criteria: (1) adjusted for BMI and COPD due to their association with the CHRNA3 rs1051730 genotype and smoking, 29, 39, [45] [46] [47] (2) adjusted for prevalent tobacco-related cancer, (3) exclusion of individuals with prevalent tobacco-related diseases (including tobacco-related cancer, COPD, and ischemic heart disease), and (4) exclusion of individuals with infections within the past 4 weeks, as this may affect the white blood cell counts.
Results

Potential Confounders
We included 104 607 individuals from the Copenhagen General Population Study, of whom 44 996 were neversmokers, 41 759 former smokers, and 17 852 current smokers. Former and current smokers seemed older compared with never-smokers and with a higher proportion of men and individuals with poor socioeconomic status, infectious disease within the past 4 weeks, and prevalent chronic diseases (Table 1 ). Former and current smokers also seemed to have a higher alcohol consumption compared with neversmokers. Blood cell indices did not seem to vary according to time since last meal (Figures IV and V in the online-only Data Supplement). Time since last meal did not differ between the different smoking groups or within the CHRNA3 rs1051730 genotype; for all groups, the median time since last meal was 2 to 3 hours with an interquartile range of 1-2 to 3-4 hours.
Observational Analyses
For white blood cells, compared with never-smokers, being a former and current smoker was associated with having increased leukocytes, including all the different subpopulations, despite adjustment for potential confounders (Figure 1 ). White blood cell counts were increased with 14% to 19% in current smokers and with 0.6% to 15% in former smokers depending on time since smoking cessation; those with >10 years since smoking cessation had the lowest increases, whereas those with <1 year since smoking cessation had the highest increases. In current smokers, higher cumulative and daily tobacco consumption was associated with having higher increases of white blood cell counts in a dose-dependent manner despite adjustment for potential confounders (Figure 2) .
For thrombocytes, similar associations could be observed. Compared with never-smokers, thrombocytes were increased with 5% in current smokers and with 0.4% to 4% in former smokers, again depending on time since smoking cessation; lowest increases for those with many years of smoking cessation and highest for those with recent smoking cessation ( Figure 3 ). Although less pronounced than for leukocytes, higher cumulative and daily tobacco consumption in current smokers was associated with having higher increases of thrombocytes in a dose-dependent manner (Figure 4) .
For red blood cell indices, compared with never-smokers, hematocrit, hemoglobin, and mean corpuscular volume were only slightly increased with 1.6% to 2.3% in current smokers, whereas erythrocytes and mean corpuscular hemoglobin concentration did not seem to differ. Except for erythrocytes, red blood cell indices did not seem to differ compared to former smokers irrespective of time since smoking cessation ( Figure 3) . Higher cumulative and current tobacco consumption in current smokers was associated with only slightly higher increases in red blood cell indices (Figure 4) .
Results were similar in complete case analyses (compare Figures 1 through 4 with Figures VI through IX in the onlineonly Data Supplement).
Genotype, Smoking, and Potential Confounders
We identified 47 237 noncarriers, 46 082 heterozygotes, and 11 288 homozygotes for the T allele of the CHRNA3 rs1051730 genotype (Table 2 ). There was no evidence of deviation from Hardy-Weinberg equilibrium (P=0.76). The CHRNA3 rs1051730 genotype was not associated with most potential confounders in the study population except with a slightly lower BMI and more prevalent COPD, as expected from previous studies. 29, 39, 45, 46 As expected, the CHRNA3 rs1051730 genotype was associated with higher cumulative and current tobacco consumption in former and current smokers. And, with higher number of current smokers and never-smokers and lower number of former smokers ( ; Figure 2 . Association of cumulative and current tobacco consumption with white blood cell counts in current smokers. Values of white blood cells are summarized as percent difference with 95% CI, obtained from multiple linear regression models adjusted for age, sex, body mass index, alcohol consumption, leisure-time physical activity, education, income, infectious disease within the past 4 wk, and any prevalent chronic disease. P were obtained from Wald's test. Some individuals lacked information on some blood cell counts (<1%). Based on individuals from the Copenhagen General Population Study. May 2019 F statistics, 32; and R 2 , 0.2%; Figure X in the online-only Data Supplement).These findings illustrate that the CHRNA3 rs1051730 genotype can be used as a largely unconfounded instrument to assess the causal association of smoking with white blood cells, thrombocytes, and red blood cell indices.
Mendelian Randomization
We observed no clear association between genotype and outcomes in never-smokers; however, the CHRNA3 rs1051730 genotype was borderline negatively associated with leukocytes, neutrophils, and monocytes in never-smokers ( Figure 5 ). CHRNA3 rs1051730 genotype in current smokers was associated with increased leukocytes, including neutrophils, lymphocytes, and monocytes but not with eosinophils or basophils, whereas the association was weakened or disappeared in former smokers ( Figure 5 ; Figure XI in the online-only Data Supplement). Age and sex adjusted % difference in leukocytes per T-allele increase was 1.15% (CI, 0.61%-1.68%) in current smokers and 0.34% (−0.01% to 0.68%) in former smokers. Corresponding values were 1.07% (0.38%-1.76%) and 0.48% (0.04%-0.92%) for neutrophils, 1.34% (0.66%-2.02%) and −0.03% (−0.48% to 0.42%) for lymphocytes, 1.50% (0.83%-2.18%) and 0.20% (−0.23% to 0.63%) for monocytes, −0.60% (−1.91% to 0.74%) and 0.18% (−0.73% to 1.10%) for eosinophils, and 0.17% (−0.94% to 1.29%) and 0.23% (−0.52% to 0.98%) for basophils, respectively.
CHRNA3 rs1051730 genotype in current smokers was associated with increased hematocrit, hemoglobin, and mean corpuscular volume and with lower mean corpuscular hemoglobin concentration but not with thrombocytes or erythrocytes ( Figure 5 ; Figure XII in the online-only Data Supplement). CHRNA3 rs1051730 genotype in former smokers was associated with thrombocytes but not with red blood cell indices. Age-and sex-adjusted % difference in thrombocytes per T allele increase was 0.38% (95% CI, −0.17% to 0.93%) in current smokers and 0.38% (0.03% to 0.73%) in former smokers. Corresponding values were 0.04% (−0.14% to 0.23%) and −0.07% (−0.18% to 0.05%) for erythrocytes, 0.34% (0.17%-0.50%) and −0.05% (−0.15% to 0.06%) for hematocrit, 0.26% (0.09%-0.43%) and −0.05% (−0.15% to 0.06%) for hemoglobin, 0.29% (0.18%-0.41%) and 0.03% (−0.04% to 0.10%) for mean corpuscular volume, and −0.07% (−0.14% to −0.01%) and −0.01% (−0.05% to 0.04%) for mean corpuscular hemoglobin concentration, respectively. Genetically determined per 10 cigarettes/day higher tobacco consumption was associated with an increase of 11.4% (5.77%-17.2%) in leukocytes, 10.5% (3.41%-18.1%) in neutrophils, 13.2% (5.86%-21.1%) in lymphocytes, 15.7% (8.41%-23.5%) in monocytes, 3.31% (1.67%-4.98%) in hematocrit, 2.52% (0.84%-4.23%) in hemoglobin, 2.98% (1.80%-4.18%) in mean corpuscular volume, and −0.74% (−1.37% to −0.11%) in mean corpuscular hemoglobin concentration ( Figure 6 ). Corresponding observationally determined per 10 cigarettes/day higher tobacco consumption were 5.13% (4.66%-5.60%), 5.42% (4.82%-6.02%), 5.52% (4.94%-6.11%), 4.03% (3.48%-4.59%), 0.82% (0.70%-0.95%), 0.79% (0.67%-0.92%), 0.56% (0.47%-0.65%), and −0.04% (−0.09-0.01), respectively.
Results were similar in genetic sensitivity analyses (Figures XIV through XVII in the online-only Data Supplement).
Discussion
In a large cohort from a general population setting, we investigated the causal relationship between tobacco smoking and white blood cells, thrombocytes, and red blood cell indices using Mendelian randomization analyses. We found that higher tobacco consumption was causally associated with increased leukocytes, neutrophils, lymphocytes, monocytes, hematocrit, hemoglobin, and mean corpuscular volume and reduced mean corpuscular hemoglobin concentration. Furthermore, the observational smoking relationships were long term for white blood cells and short term for red blood cell indices. In contrast, tobacco consumption was not causally associated with eosinophils, basophils, or erythrocytes; however, due to ambiguous results for current and former smokers, we cannot rule out a causal relationship for smoking with thrombocytes.
Mechanistically, increased white blood cells due to smoking may be explained by a systemic inflammatory response. Cigarette smoke in gas phase contains >10 15 organic radicals per puff and may thereby lead to activation and release of several proinflammatory cytokines such as tumor necrosis factor alpha and interleukin-6. 48, 49 In a complex interplay comprising different growth factors, the induced inflammation may stimulate production and release of white blood cells from the bone marrow. 48, 50 Similar patterns could also be expected for thrombocytes, as production and differentiation of megakaryocytes in the bone marrow by thrombopoietin seems to be upregulated in inflammatory conditions. 38, 48, 50 In contrast, red blood cell indices may rather be affected by carbon monoxide in cigarette smoke. Carbon monoxide leads to the formation of carboxyhemoglobin in erythrocytes; a structure with no oxygen carrying capacity. 51 Thus, hypoxic peripheral stimulation due to smoking could lead to increased hematocrit and hemoglobin as a compensatory mechanism to maintain oxygen transportation. Although erythrocyte count theoretically would also be expected to be increased by smoking, we did not observe such an association in observational or genetic analyses. Whether this discrepancy may be due to a decreased erythrocyte life span, for example, increased hemolysis in smokers, 52 or other unknown mechanisms can only be speculated on. However, the mean corpuscular volume could be increased due to alterations in lipid and protein composition in erythrocyte cell membranes arisen from oxidative stress or free radicals but also due to the toxic effects in the bone marrow of acetaldehyde from cigarette smoke. 48, 53, 54 Previous studies have been of observational study design only. [7] [8] [9] [10] [11] 14, [16] [17] [18] 38, 55, 56 Although common to them have been observing a positive association between smoking and white blood cells, thrombocytes, and red blood cell indices, there have been some conflicting results. Furthermore, these associations were dose-dependent with increasing tobacco consumption and seemed to persist for white blood cells, thrombocytes, and mean corpuscular volume in former smokers after several years of smoking cessation. 11, 14, 17, 18, 55, 56 In contrast, a prospective observational study showed that values of blood cells were already declining within days after smoking cessation. 12 Recently, we found tobacco smoking to be causally associated with systemic #Annual household income <200 000 DKK (Danish Kroner). **Fever, bronchitis, or urinary tract infection within the past 4 wk before enrollment in the study. † †Tobacco-related cancers included cancers affecting the oral cavity, nasal cavity and paranasal sinuses, pharynx, larynx, esophagus, lung, kidney, bladder and urinary tract, liver and biliary tract, stomach, pancreas, colon/rectum/anus, cervix, and myeloid leukemia. Non-tobacco-related cancers included cancers affecting the other organs except for nonmelanoma skin cancer (including squamous and basal cell carcinomas).
‡ ‡Only former and current smokers included. § §Only current smokers included.
inflammation by using leukocytes, neutrophils, and thrombocytes as biomarkers for cellular response in a Mendelian randomization approach. 38 In the present study, we now find that smoking in a dose-dependent manner also leads to increased lymphocytes, monocytes, hematocrit, hemoglobin, and mean corpuscular volume and reduced mean corpuscular hemoglobin concentration and has no effect on eosinophils, basophils, or erythrocytes. Furthermore, the observational smoking relationships were long term for white blood cells (and thrombocytes) and short term for red blood cell indices. The assumptions for carrying out Mendelian randomization studies have been rigorously described elsewhere. 26, 27 In brief, the main assumption is a sufficiently strong genetic instrument that is independent of confounders in the association between exposure and outcome and that the instrument is only associated with the outcome through the exposure. The CHRNA3 rs1051730 genotype had a relatively high F statistic for cumulative and current tobacco consumption in current and former smokers (=strong instrument) and was not associated with any measured potential confounders. Although the CHRNA3 rs1051730 genotype was associated with BMI and COPD, this is most likely a consequence of vertical pleiotropy and should therefore be considered as mediators and not confounders. 29, 38, 39, 45, 46 Nonetheless, results were similar in analyses adjusted for BMI and COPD, although this may introduce potential collider stratification bias.
Potential limitations in Mendelian randomization studies include population stratification bias and genetic pleiotropy. Since we had an ethnically homogenous population, the complicating effects of population stratification are likely to have been avoided, and since genotype distributions did not appear to differ from Hardy-Weinberg equilibrium, we have also likely avoided genotyping and population sampling errors.
Analyses were stratified according to smoking status to verify the exclusion restriction assumption and evaluate potential genetic pleiotropy for the CHRNA3 rs1051730 genotype, as previous studies have suggested this. 57 However, stratification may also introduce the possibility of collider stratification Figure 6 . Observational and genetic association of current tobacco consumption with white blood cell counts, thrombocytes, and red blood cell indices in current smokers. Values are summarized as percent difference with 95% CI, obtained from instrumental variable analysis using the control function estimator in 2 stages. Estimates from the observational analyses were adjusted for age, sex, body mass index, alcohol consumption, leisure-time physical activity, education, income, infectious disease within the past 4 wk, and any prevalent chronic disease. Estimates from the genetic analyses were obtained from the instrumental variable analyses and adjusted for age and sex. P were obtained from Wald's test. Based on individuals from the Copenhagen General Population Study. MCHC indicates mean corpuscular hemoglobin concentration; and MCV, mean corpuscular volume.
bias and lead to nonexisting associations or bias toward the null hypothesis. 58, 59 Although we did not observe a clear association between genotype and outcomes in never-smokers, there was a borderline negative association with leukocytes, neutrophils, and monocytes, which could be due to misclassification of smoking groups, collider stratification bias, or genetic pleiotropy. These observations need to be investigated further in future studies.
As indicated, a potential limitation includes misclassification of smoking groups. Smoking status could be validated using biomarkers (eg, measurement of cotinine in blood or carbon monoxide in exhaled air); however, this was not used in the present study. Although smoking status and tobacco consumption have been validated by using modern genetic approaches in the Copenhagen General Population Study, 60 there are most likely some current smokers who wrongly identified themselves as former smokers, especially among those who have recently quit smoking. Similarly, there is most likely underreporting of tobacco consumption in some current smokers, which will overestimate the genetic results in the instrumental variable analyses. Thus, caution should be taken when generalizing and extrapolating estimates from the instrumental variable analyses.
Another potential limitation in population studies is participation bias. It is well-known that nonresponders in health surveys often tend to be characterized differently compared with responders by having more disease or unhealthy lifestyle. Thus, individuals with chronic illness and smokers may not be represented equally among nonresponders and responders. Such an effect will inevitably limit the external validity of a study but likely not the internal validity and the tested hypothesis.
Lastly, a potential limitation is that measuring blood cell counts only at one time point may limit the reproducibility of the study.
Strengths of the present study include a large random sample from the general population with large numbers of former and current smokers. Furthermore, we had extensive information on genotype, blood cell indices, and tobacco smoking.
Since smoking is a potential reversible risk factor and seems to be causally associated with the hematopoietic system according to the present study, some interesting clinical questions arise. First, the myeloproliferative state found in current smokers could support previous observational studies linking smoking with Philadelphia-negative myeloproliferative neoplasms and acute myeloid leukemia. [19] [20] [21] [22] A persistent myeloid drive with ongoing systemic inflammation, evidenced by increased values of C-reactive protein, leukocytes, interleukin-6, and tumor necrosis factor alpha, 38, 48 could potentially culminate in the formation of a malignant clone or dysplastic bone marrow and lead to development of hematologic neoplasms. 23 Thus, future studies should explore a possible causal relationship between smoking and hematologic neoplasms.
Second, increased blood cell indices may increase risk of nonhematologic diseases, as suggested in some Mendelian randomization studies. 61, 62 For instance, genetically higher hematocrit shared genetic determinants with ischemic heart disease through a genetic polymorphism that affects both concentrations of hematocrit and blood lipids. 61 Smoking could potentially increase risk of ischemic heart disease by causing higher blood cell counts, higher concentration of hematocrit, and alterations in the lipid profile. In addition, genetically higher lymphocytes were associated with coronary heart disease, although statistical significance diminished after removal of major histocompatibility complexes. 62 However, future studies should explore a possible causal relationship between smoking, increased blood cell indices, and development of nonhematologic diseases.
In conclusion, we have shown that smoking causes increased blood leukocytes, neutrophils, lymphocytes, and monocytes, as well as increased hematocrit, hemoglobin, and mean corpuscular volume. The observational smoking relationships were long term for white blood cells and short term for red blood cell indices.
